Scientech Research LLC’s SpringWorks Therapeutics SWTX Stock Holding History

Scientech Research LLC’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,917	Closed	-$231K	–	832
2025 Q2	$231K	Sell	4,917 -9,200	-65%	-$409K	0.06%	498
2025 Q1	$623K	Buy	+14,117	New	+$650K	0.16%	278
2024 Q4	–	Sell	-25,866	Closed	-$829K	–	839
2024 Q3	$829K	Buy	+25,866	New	+$966K	0.17%	244

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Scientech Research LLC's SWTX Position: Q3 2025 in Review

Scientech Research LLC sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 4,917 shares — an estimated $231K sold.

Scientech Research LLC first reported a position in SWTX in Q3 2024 and held it in 3 quarters. The position peaked at $829K in Q3 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Scientech Research LLC reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Scientech Research LLC sold 4,917 SpringWorks Therapeutics shares in Q3 2025, an estimated $231K.
Scientech Research LLC first reported a position in SpringWorks Therapeutics in Q3 2024 and held it in 3 quarters.
Scientech Research LLC's SpringWorks Therapeutics position peaked at $829K in Q3 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Scientech Research LLC's 13F filing for Q3 2025, filed 14 Nov 2025.